About the Company
Endo is a specialty pharmaceutical company committed to helping everyone it serves live their best life through the delivery of quality, life-enhancing therapies. Its decades of proven success come from a global team of passionate employees collaborating to bring the best treatments forward. Together, it boldly transforms insights into treatments benefiting those who need them, when they need them.
Exchange
NASDAQ
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $ENDP News
Endo, Inc. Completes Acquisition of Endo International plc's Assets
Endo, Inc. ("Endo" or the "Company"), a newly formed entity, today announced that it has successfully completed the ...
Endo Inc. Announces Major Financing Move with $1.65 Billion in New Credit Facilities Amid Restructuring
Endo, Inc., a newly established entity, recently unveiled plans to secure new senior secured credit facilities totaling $1.65 ...
Endo International gets grant for patent granted for recombinant nucleic acid encoding collagenase
Discover the groundbreaking patent by Endo International Plc for a recombinant nucleic acid molecule encoding collagenase I and II, revolutionizing therapeutic administration methods.
Endo International's Par Pharmaceutical Expands Recall Of Treprostinil Injection
Par Pharmaceutical, Inc., a unit of Endo International plc (ENDP) Monday said it has expanded its voluntary recall to include seven ...
Endo International plc (ENDPQ)
Endo International plc (OTC: ENDPQ) announced today that one of its operating companies, Par Pharmaceutical, Inc., launched ibuprofen-famotidine 800 mg/26.6 mg tablets, a generic version of Amgen ...
Par Pharma recalls seven lots of Treprostinil injection due to potential for silicone particulates in the product solution
Par Pharma recalls seven lots of Treprostinil injection due to potential for silicone particulates in the product solution: Dublin Wednesday, April 24, 2024, 15:30 Hrs [IST] Endo ...
Endo International PLC ENDP
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Endo International set to emerge from bankruptcy
DUBLIN - Endo International plc (OTC: OTC:ENDPQ) announced today that its Chapter 11 plan of reorganization has been confirmed by the United States Bankruptcy Court for the Southern District of New ...
Endo International plc: Endo Launches Ibuprofen-Famotidine Tablets, Generic Version of DUEXIS®
DUBLIN, March 26, 2024 /PRNewswire/ -- Endo International plc (OTC: ENDPQ) announced today that one of its operating companies, Par Pharmaceutical, Inc., launched ibuprofen-famotidine 800 mg/26.6 ...
Endo International's Par Pharmaceutical Expands Recall Of Treprostinil Injection
(RTTNews) - Par Pharmaceutical, Inc., a unit of Endo International plc (ENDP) Monday said it has expanded its voluntary recall to include seven lots of Treprostinil Injection 20mg/20mL citing ...
Endo Launches Ibuprofen-Famotidine Tablets, Generic Version of DUEXIS®
DUBLIN, March 26, 2024 /CNW/ -- Endo International plc (OTC: ENDPQ) announced today that one of its operating companies, Par Pharmaceutical, Inc., launched ibuprofen-famotidine 800 mg/26.6 mg ...
Loading the latest forecasts...